Market Research Logo

Biotechnology in Brazil

Biotechnology in Brazil

Summary

Biotechnology in Brazil industry profile provides top-line qualitative and quantitative summary information including: market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Brazil biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

  • The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
  • The Brazilian biotechnology industry had total revenues of $13.1bn in 2017, representing a compound annual growth rate (CAGR) of 4.6% between 2013 and 2017.
  • The medical/healthcare segment was the industry's most lucrative in 2017, with total revenues of $4.3bn, equivalent to 33% of the industry's overall value.
  • Brazil’s industry value is more equally spread out between the segments than in other countries.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Brazil
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Brazil
  • Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Brazil biotechnology market with five year forecasts
Reasons to buy
  • What was the size of the Brazil biotechnology market by value in 2017?
  • What will be the size of the Brazil biotechnology market in 2022?
  • What factors are affecting the strength of competition in the Brazil biotechnology market?
  • How has the market performed over the last five years?
  • What are the main segments that make up Brazil's biotechnology market?


Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Braskem SA
EMS S.A.
FuturaGene Plc
Sanofi SA
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: Brazil biotechnology industry value: $ billion, 2013-17
Table 2: Brazil biotechnology industry category segmentation: $ billion, 2017
Table 3: Brazil biotechnology industry geography segmentation: $ billion, 2017
Table 4: Brazil biotechnology industry value forecast: $ billion, 2017-22
Table 5: Braskem SA: key facts
Table 6: Braskem SA: key financials ($)
Table 7: Braskem SA: key financials (BRL)
Table 8: Braskem SA: key financial ratios
Table 9: EMS S.A.: key facts
Table 10: FuturaGene Plc: key facts
Table 11: Sanofi SA: key facts
Table 12: Sanofi SA: key financials ($)
Table 13: Sanofi SA: key financials (€)
Table 14: Sanofi SA: key financial ratios
Table 15: Brazil size of population (million), 2013-17
Table 16: Brazil gdp (constant 2005 prices, $ billion), 2013-17
Table 17: Brazil gdp (current prices, $ billion), 2013-17
Table 18: Brazil inflation, 2013-17
Table 19: Brazil consumer price index (absolute), 2013-17
Table 20: Brazil exchange rate, 2013-17
List of Figures
Figure 1: Brazil biotechnology industry value: $ billion, 2013-17
Figure 2: Brazil biotechnology industry category segmentation: % share, by value, 2017
Figure 3: Brazil biotechnology industry geography segmentation: % share, by value, 2017
Figure 4: Brazil biotechnology industry value forecast: $ billion, 2017-22
Figure 5: Forces driving competition in the biotechnology industry in Brazil, 2017
Figure 6: Drivers of buyer power in the biotechnology industry in Brazil, 2017
Figure 7: Drivers of supplier power in the biotechnology industry in Brazil, 2017
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Brazil, 2017
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Brazil, 2017
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Brazil, 2017
Figure 11: Braskem SA: revenues & profitability
Figure 12: Braskem SA: assets & liabilities
Figure 13: Sanofi SA: revenues & profitability
Figure 14: Sanofi SA: assets & liabilities

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report